Neurology Topic Reviews Flashcards

(255 cards)

1
Q

Why should all children with an iris coloboma have a comprehensive eye exam?

A

Iris coloboma may be the only externally visible part of a more extensive coloboma involving the fundus and optic nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Description of a coloboma?

A

Defect such as a gap, notch, fissure or hole

May be described as a “keyhole” appearance

May be described as an “irregular” defect

May occur in the eyelid, iris, fundus, optic nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What can coloboma be associated with?

A

Micro-opthalmia (small eye)

Nystagmus

Visual field defects (if retina involved)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What syndromes are most associated with coloboma?

A

CHARGE (Coloboma, Heart defects, Atresia choanae, Growth restriction, Genital abnormalities, Ear abnormalities)

T18

Walk Warburg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is aniridia?

A

Partial or complete absence of the iris

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Is aniridia usually unilateral or bilateral?

A

98% are bilateral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What other conditions are highly associated with aniridia?

A

Glaucoma develops in up to 75% of patients

20% of sporadic cases will develop Wilm’s tumour (gene for aniridia is very close to the gene for Wilm’s tumour)
- children with sporadic aniridia need to be screened with renal US q3-6months until age 5yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Damage to the optic nerve with visual field loss is called:

A

Glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What condition should you suspect in an infant with “big, beautiful eyes”

A

Congenital glaucoma

Abnormal eye growth leads to large eyes

Corneal swelling is caused by cloudy cornea with photophobia and tearing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors for infantile glaucoma?

A

Previous intraocular surgery (including pediatric cataracts)

Uveitis
Steroid use
Syndromes
- Sturge Weber
- NF 1
- Marfan

Family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Classic triad of glaucoma?

A

Epiphora (tearing)
Photophobia
Blepharospasm (eyelid squeezing in response to light)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Untreated glaucoma leads to what

A

Blindness

Needs urgent review by Ophtho

Definitive management is surgical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the classic presentation of botulism

A

Symmetric descending paralysis

Cranial nerve dysfunction / Bulbar palsies

Urinary retention and constipation - can precede other symptoms

Resp difficulties

DTRs can be preserved or lost

Absence of sensory deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sources of exposure to Clostridium botulinum?

A

Classically associated with raw honey

Associated with home-canned foods, restaurant prepared foods, commercial foods sealed in plastic pouches

Can also be wound infection related → results from spore gemination and colonization of traumatized tissue by C.botulinum → similar pathophysiology to tetanus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pathophysiology of botulism?

A

Irreversible inhibition of Ach release at presynaptic nerve terminal of body’s NMJs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Compare SMA vs botulism in an infant with hypotonia/ weakness?

A

Botulism
- should be more acute vs presenting after several weeks or months
- does not spare the cranial nerves
- descending paralysis

SMA
- more subacute presentation
- upper cranial nerves leading to most facial muscles preserved so patients have alert expression, furrowed brow, normal eye movements (but they do still have weakness of bulbar muscles)
- DTRs almost always lost
- lower limbs affected more than upper limbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Treatment of botulism?

A

Baby BIG (botulism immune globulin)
Need to order from California

If patient > 1 year, can give antitoxin

Treat CLINICALLY, do not wait for stool toxin test to come back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For SMA (Spinal Muscular Atrophy), what is the inheritance pattern and gene affected?

A

Autosomal Recessive

SMN1 gene (biallelic deletion on chr 5q)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the pathophysiology of SMA (Spinal Muscular Atrophy)?

A

Biallelic deletion of the SMN1 gene (on chr 5q) –> results in low levels of SMN protein –> degeneration and loss of motor neurons in the anterior horn of the spinal cord and brainstem nuclei –> results in progressive weakness and atrophy .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The severe infantile rapidly progressive form of Spinal Muscular Atrophy (SMA) Type 1 occurs in 25% of SMA cases. Describe the presentation of SMA Type 1?

HINT
- Age on onset of symptoms?
- Symptom progression?
- Typical age of death if not treated?

A

Age on onset of symptoms?
- Presents before 6 months of age

Symptoms?
- Generalized WEAKNESS (Never able to sit, stand, walk)
- Severe SYMMETRIC FLACCID PARALYSIS, hypotonia
- ALERT EXPRESSION, furrowed brow
- NORMAL EOMs
- BULBAR MUSCLE WEAKNESS (weak cry, poor suck and swallow reflexes, pooling of secretions, tongue fasciculations, and increased risk of aspiration, FTT)
- Progressive RESP FAILURE, paradoxical breathing
- Bell-shaped chest deformity

Typical age of death if not treated?
- >65% die by age 2yr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The late infantile slower progressive form of Spinal Muscular Atrophy (SMA) Type 2 occurs in 50% of SMA cases. Describe the presentation of SMA Type 2?

HINT
- Age on onset of symptoms?
- Symptom progression?
- Typical age of death if not treated?

A

Age on onset of symptoms?
- Presents between 6-18months of life

Symptoms?
- Generalized WEAKNESS (Able to sit (delayed), Never able to stand or walk). PROXIMAL WEAKNESS (legs > arms)
- SPARING OF FACE AND EOMs
- FASCICULATIONS with tongue atrophy
- AREFLEXIA
- Fine tremor-like form of myoclonus in distal limbs
- DYSPHAGIA
- Resp muscle weakness & restrictive lung disease. RESP INSUFFICIENCY.
- Progressive scoliosis
- Joint contractures

Typical age of death if not treated?
- 10-40yrs, confined to wheel chair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The juvenile form of Spinal Muscular Atrophy (SMA) Type 3 occurs in 25% of SMA cases. Describe the presentation of SMA Type 3?

HINT
- Age on onset of symptoms?
- Symptom progression?
- Typical age of death if not treated?

NOTE: SMA-Type III is a mimic of Muscular Dystrophy

A

Age on onset of symptoms?
- Patients appear normal in infancy. Onset > 18 months - adulthood.

Symptoms?
- Muscle WEAKNESS (Able to sit and stand. Able to walk with assistance.)
- Pronounced PROXIMAL muscle weakness (presents as fall, trouble climbing stairs, waddling gait, winged scapula, gower sign)
- Eventually lose ability to stand and walk independently with time and become wheelchair dependent
- FASCICULATIONS

Typical age of death if not treated?
- Live well into adulthood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the gold standard test to diagnose SMA (Spinal Muscular Atrophy)? Other helpful investigations?

A

Genetic Testing of SMN gene deletion (Gold standard)

Other Helpful Tests:
- Muscle biopsy: Diagnostic but no longer required due to genetics. Shows circular atrophic type 1 and 2 muscle fibers.
- EMG: Diagnostic but no longer required due to genetics. Abnormal spontaneous activity with fibrillations and positive sharp waves.
- Motor nerve conduction studies: Normal (+/- mild slowing in terminal stages of the disease). Helps distinguish SMA from peripheral neuropathy.
- CK: normal or mildly elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

SMA (Spinal Muscular Atrophy) previously had a poor prognosis. There are multiple new medications that are indicated nowadays, please describe each Mechanism of Action, Route and Side-effects of each:

  • Nusinersan (Spinraza)
  • Onasemnogene abeparvovec (OAX)
  • Risdiplam
A

Nusinersan (Spinraza)
- MOA: GENE MODIFICATION drug that increases overall SMN protein production.
- Route: Intrathecal loading dose + q4mo intrathecal maintenance doses.
- Side-effects: Thrombocytopenia, Coagulopathy, Renal toxicity.
- Patient Age: Approved for patients <2mo

Onasemnogene abeparvovec (OAX)
- MOA: GENE REPLACEMENT therapy via recombinant AAV9 that gives you an SMN gene.
- Route: Single IV infusion
- Side-effects: Liver injury, Thrombocytopenia, Inc troponin.
- Patient Age: Approved for patients <2mo

Risdiplam
- MOA: SMN2 directed RNA splicing modifier resulting in increased full-length SMN protein.
- Route: PO daily
- Patient Age: Approved for patients >2mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How does juvenile myoclonic epilepsy present?
early adolescence with myoclonic jerks in the MORNING (causes pts to drop things and seem "clumsy") 90% progress to GTC seizures and 33% develop juvenile absence seizures neurodevelopmentally normal teens 8-20 yrs old onset
26
triggers for juvenile myoclonic epilepsy?
Sleep deprivation, alcohol, photic stimulation
27
What age group are breath holding spells most common in
6-18 months However can last up to 8 years old (most resolve by age 4, all will resolve by age 8)
28
What are the types of breath holding spells and which is most common?
Cyanotic Type (Dominant subtype): apnea and cyanosis after anger/frustration Pallid Type: limp, diaphoretic and pale after injury/pain Mixed Type
29
What investigations should you order with suspected breath holding spells?
CBC and ferritin Association with iron deficiency anemia
30
Any increased concern if seizure like movements after breath holding spells?
No, occasionally can actually have a brief seizure after a breath holding spell NO increased risk for seizure disorders in the future
31
What is the management for breath holding spells?
- Reassure parents (ignore breath holding spell once it has started) - Consider iron supplementation trial Note: Median age of remission 4yrs, 100% will resolve by age 8yrs. Usually neurodevelopmentally normal. No increased risk of seizures disorder in future.
32
EEG findings of juvenile myoclonic epilepsy?
4-6 Hz polyspike-and-slow-wave discharges photosensitvity
33
treatment of juvenile myoclonic epilepsy?
VPA, Keppra typically do NOT outgrow their seizures (lifelong tx) note: Do NOT use carbamazepine or phenytoin with absence or myoclonic seizures
34
how long does a patient need to be seizure free before stopping an anti-epileptic?
2 years
35
What 3 classifications of symptoms are present in anti NMDA receptor encephalitis?
Neuropsychiatric symptoms (behaviour/personality changes, irritability, aggression, hypersexuality, depression, anxiety, hallucinations, etc) Neurologic (seizures, movement disorders, chorea, nystagmus, oromotor dyskinesias, etc) Autonomic symptoms (labile BP, Temp instability, cardiac arrhythmias, hypoventilation, HR variability, etc)
36
Define convulsive status epilepticus? (CPS)
continuous generalized tonic-clonic (GTC) seizure activity with loss of consciousness for longer than 30 minutes, or two or more discrete seizures without a return to baseline mental status "early/impending status epilepticus" is continuous seizure >5min or discrete seizures lasting >5min without full recovery of consciousness between seizures
37
Management of status epilepticus?
ABCs- position on side, suction, reposition on back, jaw thrust, 100% FiO2 face mask, CRM, obtain IV (ideally 2 large bore). Bag or intubate if bradycardia, hypotension and poor perfusion Rapid history - hx of seizure disorder? use of antiepileptic? allergies? Terminate seizure Tests - POC blood glucose (if <2.6, give 5g/kg dextrose - rule of 50s, eg 5 mL/kg of D10W), recheck BG q3-5min -gas with lytes give abx if suspicious for meningitis (do not delay for cx)
38
Approach to terminating status epilepticus? (CPS)
give next med if pt still seizing for 5min Benzo (IN, buccal, IM or IV if available) Repeat benzo (IV ideally) 2nd line: fospheny*, pheny, phenobarb, levetiracetam, VPA (limited availabilityin Canda) *note fospheny is the only second line drug that has IM option, all others need IV or IO try a different 2nd line (don't combine fospheny and pheny as the two 2nd line options) consider dose of pyridoxine if <18mo old consult PICU, prepare for intubation and anesthetic medication, tx for refractory status epilepticus might include midaz infusion
39
which antiepileptic has the most respiratory depression?
phenobarbital esp when combined with benzodiazepines (first line meds) MOA of phenobarb is similar to benzos thus may be less effective if the sz has been refractory to benzo
40
which antiepileptic should you avoid if TCA or theophylline overdose?
phenytoin
41
side effects of fosphenytoin and phenytoin?
cardiac arrhythmias, bradycardia, and hypotension (need continuous BP and ECG monitoring) specific to phenytoin: - extravasation of phenytoin can result in severe subcutaneous irritation characterized by edema, discolouration, and pain distal to the site of administration (NEVER give IM) - gum hypertrophy
42
best 2nd line epileptic for children <6mo old, prolonged febrile seizures or seizures caused by toxic ingestions or drug withdrawal?
phenobarbital (but not if pt has resp depression or hemodynamic instability)
43
best 2nd line epileptic for children with respiratory depression or hemodynamic instability?
levetiracetam (Keppra) also a great choice for kids on many meds as it has the lease interaction with other meds (eg kids on chemo or anti-inflammatories)
44
Contraindications to using valproic acid?
liver disease mitochondrial disease (even suspected) <2yrs old with unexplained developmental delay
45
why do we give pyridoxine to children <18mo with refractory seizure?
in case the seizure is being caused by an undiagnosed metabolic disorder trial of pyridoxine (vitamin B6) 100 mg by IV initially, then 50 mg IV/PO BID, should be considered if there is a failure to respond to antiepileptics
46
work up following an unexplained (non-febrile) seizure?
gas, lactate, lytes, glucose, CBC-D, Cx anticonsulvant levels on long term meds urine/blood tox screen serum Calcium/Mag, BUN, liver enz, ammonia consider LP if no raised ICP CT if raised ICP, focal neuro deficits, trauma
47
side effect of levetiracetam?
aggression, "Keppra rage" (20%) suicidality (rare)
48
side effect carbamazepine?
rash hepatitis anemia
49
side effect of topiramate?
weight loss kidney stones
50
side effect of lamotrigine?
rash (5%) start low and go slow
51
side effect of valproic acid (VPA)?
weight gain hepatitis pancreatitis low platelets
52
side effect of vigabatrin?
renal toxicity (5%)
53
Red flag features for sacral dimples, warranting spine US or MRI to assess for spinal dysraphism?
Location above gluteal fold > 2.5cm from anal verge > 5mm width across base Deep, unable to visualize base Multiple dimples tuft of hair hemangioma subcutaneous appendage if imaging comes back abN, refer to neurosurg
54
what is a brachial plexus injury?
weakness or flaccid paralysis of the upper extremity diagnosed soon after birth, results from injury of one or more cervical and thoracic nerve roots (C5–T1) often a debilitating condition with long-term effects
55
risk factors for brachial plexus injury?
*shoulder dystocia* (injury sustained with birth) *humeral/clavicle facture macrosomia (>4.5 kg) LGA fetal or birth asphyxia maternal bicornate uterus (injury sustained in utero and during descent) pre-existing maternal diabetes forceps or vacuum-assisted delivery episiotomy
56
Describe the key features for brachial plexus injuries I to II of the Narakas classification system
I - Classic Erb's Palsy (C5/C6)- shoulder adducted, internally rotated, elbow extended II - Extended Erb's (C5,6,7)- same with wrist/fingers flexed ("waiter's tip") as C7 additionally involved (photo)
57
Describe the key features for brachial plexus injuries III and IV of the Narakas classification system
III and IV additionally have C8 and T1 injury (C5-8, T1) resulting in total palsy with complete flaccid paralysis III - no Horner IV - with Horner syndrome (C5-T1 with sympathetic chain involvement) - miosis, ptosis and anhidrosis
58
which types of brachial plexus injury are associated with higher rates of spontaneous recovery?
I (Classic Erb's palsy) and II (extended Erb's palsy) - recovery rates 70-95% while almost 80% of children with global C5-T1 injuries (aka III and IV) have persistent deficits at 18 mo
59
long-term consequences of persistent neonatal brachial plexus injury?
weakness contractures limb length discrepancy cosmetic deformities
60
pathophysiology of brachial plexus injuries? (CPS)
Variable: Neuropraxia (a temporary conduction block due to interruption of the myelin sheath, with recovery of full function generally within weeks) Axonotmesis (disruption of the nerve fibers and myelin sheath, with some function returning within months but incomplete recovery) Neurotmesis (nerve disruption and avulsion of the nerve roots from the spinal cord, with no chance of recovery)
61
What is the most common pituitary tumour in adolescents?
Prolactinoma
62
What endocrine syndrome can be associated with prolactinoma?
MEN type 1
63
Approach to evaluating neonatal brachial plexus injuries? (CPS)
assess for RF (eg shoulder dystocia) MSK/neuro exam: passive + active ROM, reflexes CXR and humeral XR to assess for humeral/clavicle fracture chest asymmetry or elevated hemi-diaphragm may indicate phrenic injury assess for Horner syndrome
64
What is the definition of microadenoma vs macroadenoma (in prolactinoma)
Microadenoma <1cm Macroadenoma > 1cm
65
Which patients with brachial plexus injury should receive operative nerve repair?
pts 3mo and older with persistent deficits refer to brachial plexus multidisciplinary health care team if recovery incomplete at 1 mo (ie active elbow extension and flexion remain absent)
66
Symptoms of prolactinoma?
Depends on degree of hyperprolactinemia (can cause primary or secondary amenorrhea, galactorrhea) Can cause headache Can cause delayed puberty Macroadenomas can be associated with other pituitary hormone deficiencies (particularly GH deficiency)
67
Presentation of subarachnoid hemorrhage (SAH)?
severe direct blow or shearing forces that tear small vessels in pa mater SAH rarely alone causes raised ICP SAH can cause cerebral vasospasm, cerebral hypoxia and diffuse brain swelling (DBS)
68
Presentation of subdural hematoma (SDH)?
shearing forces (eg rapid accel-decel from MVA or non-accidental injury) leading to tearing of bridging veins in subdural space presents with depressed mental status, headache, vomiting, seizure +/- loss of consciousness at time of injury crescentic lesion on CT
69
Treatment of subdural hematoma (SDH)?
usually nonsurgical unless severe
70
Presentation of epidural hematoma?
direct blow to head with skull fracture and laceration of epidural vessels classic description: initial loss of consciousness followed by "lucid interval" (although the minority of pts present this way) lethargy, vomiting, headache biconvex lesion adjacent to skull
71
treatment of epidural hematoma?
immediate neurosurg consult and craniotomy with evacuation of blood
72
What is cerebral palsy?
heterogeneous group of disorders due to a static insult to developing fetal or infant brain leading to impaired motor function (tone, posture, movement) that limit activity non-progressive, but clinical manifestations may change over time as the child develops
73
Causes of cerebral palsy?
prematurity - associated with periventricular leukomalacia (PVL) or intraventricular hemorrhage (IVH) perinatal infection - most common RF for premature neonates developing CP HIE Perinatal Stroke Structural brain malformation (teratogen, intrauterine infection, genetics)
74
Types of cerebral palsy? (General classification)
SPASTIC (MOST COMMON): Spastic Diplegia Spastic Hemiplegia Spastic Quadriplegia DYSKINETIC (involuntary movements): *assoc'd with HIE injury to basal ganglia Choreo-athetotic -chorea: dance-like movements -athetosis: writhing Dystonic Ataxic
75
Presentation of spastic cerebral palsy?
Spastic Diplegia - bilateral legs involved -assoc'd with PVL Spastic Hemiplegia -unilateral arm usually - presents 6mo+ with early hand preference -assoc'd with perinatal Stroke Spastic Quadriplegia -all 4 limbs -usually also epilepsy, vision/cognitive issues - assoc'd severe PVL/IVH
76
Presentation of dyskinetic cerebral palsy
involuntary movements *assoc'd with HIE injury to basal ganglia Choreoathetotic CP -chorea: dance-like movements -athetosis: writhing -assoc'd with kernicterus from hyperbili Dystonic: abN posturing Ataxic CP: clumsy, uncoordinated, slow/jerky speech
77
Associated conditions with cerebral palsy? (5)
50% are intellectually disabled epilepsy vison and hearing problems speech disorders orthopedic problems
78
Evaluation of cerebral palsy?
MRI - may see prior stroke, HIE, PVL or brain malformation consider genetic or metabolic testing
79
Treatment of microadenomas vs macroadenomas (prolactinomas)?
Microadenomas <1cm only treat if symptomatic Macroadenomas ALWAYS treat Treatment = dopamine agonists Cabergoline is the drug of choice Rare cases - need trans-sphenoidal surgery
80
What is convulsive syncope?
Brief motor activity, including tonic extension of the trunk and limbs or several clonic jerks, can occur in uncomplicated syncope The severity of convulsive symptoms in syncope varies from subtle signs that are often overlooked to more dramatic symptoms that mimic an epileptic seizure. The combination of seizure-like motor activity in the setting of syncope is sometimes referred to as convulsive syncope. Convulsive syncope is usually brief (<20 seconds) Patients usually wake up quickly after a syncopal event and may recognize their surroundings within a minute or so. Prolonged confusion or lethargy lasting several minutes or longer favors seizure
81
Health surveillance of Gross Motor Function Classification System (GMFCS) I and II cerebral palsy? (CPS) In OSCE, state you would use the CPS CEREBRAL PALSY HEALTH AND WELLNESS RECORD to structure interview with patient/family (Study this for OSCE!)
ORTHO: monitor for... - pain (from increased muscle tone, ill-fitting brace, constipation, GERD) - hip subluxation/dislocation (consequence from delayed weight-bearing) - scoliosis (esp around pubertal growth spurt) - hypertonia (may need botulinum toxin A injection or oral baclofen if limiting function or painful) - monitor for obesity (more sedentary) -OT/PT DEVELOPMENT - vision testing (refractive errors, strabismus, and visual field loss from brain injury) - autism screen (CP kids higher risk) - psychoeducational assessment (more inattention, impulsivity, language difficulties) -Body Image/Self- esteem -SW, SLP +/- developmental pediatrician
82
orthopedic devices helpful in CP?
ankle-foot orthosis (AFO) (increases stability with stairs and uneven surfaces, stretches hypertonic calf muscles) knee-extension splints and hand-resting splints (prevent muscle contractures) supramalleolar orthosis modified constraint therapy or hand-arm bimanual therapy railings/ramps to hold(Avoid falls)
83
(CPS) When caring for children with life-altering conditions such as CP, what are the on the six ‘F-words’ in childhood disability to focus on?
"function, family, fitness, fun, friends, and future" "Promoting family and child involvement in recreational and community activities, and developing connections with inclusive local programs can build confidence and individual ability while enhancing well-being"
84
Tools used to make an accurate diagnosis of cerebral palsy?
These 3 can be combined to make an accurate diagnosis before 6 mo Hammersmith Infant Neurological Examination (HINE)) Prechtl’s General Movement Assessment) MRI FYI, we can estimate gross motor trajectory based on their GMFCS category by age 2. Most of a child’s motor development has been achieved by 5 years of age
85
Surgical options in cerebral palsy?
Selective dorsal rhizotomy (SDR) = nerve rootlets severed to reduce spasticity - best for GMFCS levels II and III implantation of a reservoir pump and catheter to deliver Intrathecal Baclofen (ITB) - best for GMFCS levels IV and V - high rates of complications (catheter dislodgement; pump malfxn) Deep brain stimulation - only for severe, refractory dystonia
86
Health surveillance of Gross Motor Function Classification System (GMFCS) III and IV cerebral palsy? (CPS)
same as GMFCS I and II, plus monitoring for: - Pelvic XR and exam q6-12 mo (hip subluxation) --> refer to ortho if >30% of femoral head uncovered by pelvis (may need soft tissue release or hip reconstructive surgery) -vit D, dietary calcium, wt bearing activities (reduce osteoporosis) - VFSS as needed for swallowing difficulty; pace intake, maintain upright position when eating, and thickened liquids to prevent aspiration
87
Describe treatment of spasticity and dystonia in cerebral palsy patients?
1st line: Oral Baclofen - side effects: constipation and sedation **rebound hypertonia if stopped abruptly if focal hypertonia, botulinum toxin A injection periodically https://www.aacpdm.org/publications/care-pathways/dystonia-in-cerebral-palsy (linked in CPS)
88
Which cerebral palsy patients should be considered for selective dorsal rhizotomy (SDR) surgery (to reduce spasticity)?
- preterm with PVL white matter injury - dyskinesia - MSK contracture - "possess antigravity muscle strength" - "Live with positive psychosocial factors (e.g., they can access and participate in a therapy program)" Benefits of SDR appear to be greatest in individuals with CP GMFCS levels II and III
89
how do childhood absence seizures present?
Blank stare 5-30sec, 100s times per day +/- eyelid flutter/upward eye rolling NO post-ictal, no aura May initially be misdiagnosed as “inattention” or “learning disability” Children typically cognitively normal
90
age of onset of absence seizures?
4-7 yrs for childhood absence seizures Glut1 deficiency – EARLY ONSET ABSENCE SEIZURE (baby/toddler) – treat with keto diet
91
EEG pattern of childhood absence seizures?
classic 3 Hz generalized spike and wave Increased risk of other seizure types (GTC)
92
treatment of childhood absence seizures?
Ethosuximide, Valproic Acid (VPA) >90% remit by adolescence
93
presentation of Landau Kleffner?
Child develops normally until ~3-6y, then begins to lose language function Often behave as if they are deaf initially, then stop talking >70% have clinical seizures, several types memory aid: Kleff is deaf
94
EEG findings of Landau Kleffner?
Diffuse slow spike-waves in SLEEP 1.5-2.5Hz at all slow sleep stages epileptiform discharges in temporoparietal-occipital lobes
95
Treatment of Landau Kleffner?
Corticosteroids, IVIg VPA, Ethosuximide, clonazepam, clobazam Avoid: carbamaz/oxcarb, lamotrigine, topiramate (worsen discharges)
96
what is lennox-gastaut?
"final common pathway: for many epilepsy conditions severe, refractory epilepsy multiple seizure types, usually daily significant intellectual impairment difficult to treat
97
what is dravet syndrome?
Refractory epilepsy starting first year of life POOR PSYCHOMOTOR DEV'T outcomes Pts have prolonged, often febrile, clonic sz in setting of normal cognitive and motor development prior to sz onset difficult to treat
98
Presentation of PRES?
Patients present with headaches, encephalopathy, visual disturbances, and/or seizures in the setting of high BP
99
Provoking factor for PRES?
Typically a rapid increase in blood pressure May be due to a number of causes
100
Risk factors for PRES?
Chemotherapy or cytotoxic drugs (tacrolimus is a common agent) Kidney disease Post organ transplantation Autoimmune disease Eclampsia
101
Neuro exam in PRES?
May have visual field deficits (eg hemianopia, visual neglect, cortical blindness) May have upper motor neuron signs eg hyperreflexia, Babinski May have papilledema
102
Classic MRI findings of PRES?
Symmetrical white matter changes in the posterior cerebral hemispheres
103
Treatment of PRES?
Urgent treatment of hypertension Treat underlying etiology (eg temporarily discontinue provoking medications, treat underlying disease) Antiepileptic agents if seizures
104
What is ADEM?
Acute disseminated encephalomyelitis An entity characterized by acute presentation of encephalopathy presumed to be due to a single demyelinating/autoinflammatory event
105
Presentation of ADEM?
Can have focal neuro deficits including motor, sensory, brain stem dysfuntion (eg dysphagia, dysarthria, oculomotor palsies) or ataxia May have seizures May present with or without fever May include other nonspecific symptoms (vomiting, behavioural changes, headache) Typically LP findings show lymphocytosis < 100 WBC
106
Common triggers for ADEM
Viral infections (commonly a viral infection 1-8 weeks before neurologic symptoms) Immunizations
107
MRI findings for ADEM?
Diffuse lesions primarily in the cerebral white matter
108
First line therapy for ADEM?
Steroids IVIG reserved for refractory cases
109
Dx of ADEM?
Clinical diagnosis that is retrospective after other causes have been ruled out MRI findings can be helpful Diagnosis requires that no new clinical or MRI findings emerge 3 months or more after initial episode of ADEM
110
Distinguishing between ADEM and first presentation of pediatric MS?
- MS typically will not present with fever or encephalopathy - MS can have multiple episodes of symptoms, whereas ADEM is a single episode by definition - Neuroimaging for MS tends to have more discrete white matter changes and will not involve gray or deep brain matter as it can for ADEM
111
Presentation of transverse myelitis?
Rapidly progressing bilateral weakness over hours to days - will typically involve legs and sometimes arms (if C-spine is involved) Most patients will have a sensory level Bowel/bladder dysfunction UMN signs: initially low tone and diminished DTRs that progress to increased tone and hyperreflexia
112
Causes of transverse myelitis?
Postinfectious (West Nile virus, herpes viruses, HIV, Lyme, Mycoplasma, syphilis) CNS demyelinating disorder (MS, ADEM) Systemic autoimmune diseases (SLE, Sjogren, sarcoidosis)
113
Differences between transverse myelitis and GBS?
TM: - Inflammation of the spinal cord (CNS) - Often post-infectious, autoimmune, or idiopathic - Sensory level often present - Reflexes initially normal or brisk, then decreased - Bladder/bowel dysfunction common - Cranial nerve involvement very rare - LP shows pleocytosis GBS: - Immune-mediated demyelination of the peripheral nerves. - Often follows viral or bacterial infection (e.g., Campylobacter jejuni) - Sensory loss but no sensory level - Absent DTRs early - Can have autonomic instability (eg HR) - Can have cranial nerve involvement - LP shows albuminocytologic dissociation (high protein, normal WBC)
114
MRI findings for GBS
thickened cauda equina and intrathecal nerve roots
115
classic clinical presentation of GBS
numbness and parasthesia followed by ascending weakness absent DTRs or hyporeflexia +/- bulbar involvement (dysphagia and facial weakness)
116
treatment of GBS
Treat with IVIG (for 2, 3, or 5 days) Hastens recovery, but does not alter long term outcome Plasmapheresis and/or immunosuppressive drugs are alternatives, steroids not as effective Differential recovery if axonal vs. demyelinating
117
What condition is caused by expansion of a CTG-trinucleotide repeat
Myotonic dystrophy type 1 AD inheritence Anticipation: trinucleotide repeat count increases over successive generations --> next generation presents earlier
118
Congenital presentation of myotonic dystrophy?
profound hypotonia facial diplegia poor feding arthrogryposis (congenital joint contractures - especially of the legs) respiratory failure truncal and appendicular weakness areflexia or marked hyporeflexia
119
Childhood presentation of myotonic dystrophy?
If presenting outside the neonatal period: usually presents before age 10 Cognitive and behavioural problems Executive dysfunction Cardiac rhythm disturbances Skeletal and respiratory muscle weakness Cataracts daytime somnolence Typical pattern of weakness: facial muscles, hand intrinsic muscles, ankle dorsiflexors Myotonia: delayed relaxation after muscle contraction (grip and can't let go after handshake)
120
Difference between meningocele and myelomeningocele?
Meningocele - protrusion of meninges through a spinal defect, resulting in the appearance of a cyst over lumbar spine - spinal cord remains intact - usually neurologically asymptomatic Myelomeningocele: - protrusion of meninges and spinal roots through defect (cyst remains covered by meninges) - results in severe neurologic complications with variable loss of function below the spinal level of the defect
121
What allergy is common in patinets with spinal cord dysraphisms?
Latex allergy Up to 70% of patients have some type of allergy to latex (ranging from rash to anaphylaxis)
122
What is neuroblastoma?
tumour of neural crest cells?
123
what age does neuroblastoma typically present?
cancer of INFANCY (usually <5yrs)
124
What is the pathophysiology of neuroblastoma?
- Neural crest cells normally make up the sympathetic ganglia and adrenal medulla - the sympathetic nervous system neurons release norepinephrine - adrenals release epinephrine NE and Epi break down in Homovanillic acid (HMA) + vanillylmandelic acid (VMA) the neuroblastoma can develop in the adrenals (50%) or anywhere along sympathetic nervous system (paraspinal, mediastinum, neck) -tumour release of HMA and VMA
125
genetics of neuroblastoma?
may be somatic or germline mutation somatic (98%) heritable (2%) - familial neuroblastoma (ALK gene) - PHOX2B Neurocristopathy syndrome = Congenital neuroblastoma + Hirschsprung dz + congenital hypoventilation syndrome
126
Presentation of neuroblastoma?
constitutional sx: wt loss, fever, sweating, fatigue firm, fixed, non-tender abdo mass Mass may press on organs --> abdo pain, constipation, UTI, HTN (renal artery) Emergent presentations: spinal cord compression, stridor (compression from the mass), SVC syndrome Horner’s syndrome (anhidrosis, ptosis and miosis) from the mass pressing on the sympathetic nerves Paraneoplastic syndromes: - Opsoclonus-myoclonus ataxia syndrome - VIPoma - Excessive catecholamine secretion syndrome (pheo-like with HTN crisis)
127
Which paraneoplastic syndromes are associated with neuroblastoma?
Opsoclonus-myoclonus ataxia syndrome VIPoma Excessive catecholamine secretion syndrome (pheo-like with HTN crisis) - flushing, sweating, HTN
128
What is Opsoclonus-myoclonus ataxia syndrome ?
paraneoplastic syndrome associated with neuroblastoma - rapid, dancing eye movements - rhythmic jerking of the limbs - ataxia - sleep regression, irritability **opsoclonus-myoclonus ataxia is associated with LOW RISK tumours
129
How do we treat Opsoclonus-myoclonus ataxia syndrome?
IVIG, rituximab and steroids
130
what is VIPoma?
neoplastic syndrome associated with neuroblastoma intractable, secretory diarrhea (persists when fasting)
131
What percentage of patients with neuroblastoma have metastatic disease at the time of initial evaluation?
50%
132
where does neuroblastoma metastasize to?
- Spine -> muscle weakness, incontinence - Bones (50%) -> bone pain, fractures (skull fracture = racoon eyes) - Bone Marrow -> cytopenias (fatigue from anemia, bruising from low plt, infections from low neuts) - Cervical LN --> Horner syndrome - Liver mets = if large, coagulopathy - if mediastinal mass, resp distress, laryngeal nerve compression (hoarse)
133
Physical exam features of neuroblastoma?
“blueberry muffin” rash (mets to subcutaneous tissue) proptosis, “raccoon eyes” (metastasis to orbital bone) heterochromia (different colored irises) if cervical neuroblastoma
134
Which investigations should be sent in neuroblastoma?
Urine catecholamines VMA/HVA SPECT CT (staging) Tumour biopsy/resection Metastasis Work-Up: - CBC (cytopenia in BM mets), bone marrow aspirate and biopsy - MIBG - nuclear med imaging, attaches to neuroblastoma cell receptors, looking for distant mets - LFTs
135
How do we risk stratify neuroblastoma?
Low Risk / Better prognosis if: - dx <18mo (younger the better) - localized disease - hypoploidy histology - absence of MYN-C oncogene
136
Treatment of neuroblastoma?
Low risk = surveillance, most will regress without intervention. If localized and easily resectable, can also use surgery High risk = surgery, chemo, radiation, +/- stem cell transplant (50% survival, 5-yr survival 8%)
137
What is Rett syndrome?
Brain disorder from de novo mutation in MECP2, leading to defective MECP2 protein which is critical to normal brain function
138
genetics of Rett syndrome?
occurs in females MECP2 gene de novo mutation located on the X chromosome (thus not usually heritable) X-Linked Dominant inheritance
139
Presentation of Rett syndrome
intellectual disability (mod/severe) normal development until ~18mo followed by loss of speech and purposeful hand use, stereotypical hand movement (hand-wringing or washing) gait ataxia deceleration of head growth (acquired microcephaly)
140
Diagnosis of Rett syndrome?
MECP2 molecular analysis
141
What is myeloschisis?
Most severe form of spinal cord dysraphism Protrusion of meninges and spina roots thorugh defect with an open lesion over the back, resulting in a direct communication between the spinal canal and the external environment High risk for CNS infections
142
LP is NOT contraindicated in which form of spinal dysraphism?
Spina bifida occulta
143
Prevention of spinal dysraphism?
Prenatal supplementation with folic acid Minimum 1mg daily, some resources say up to 5mg daily
144
What medication that a mother is taking increases risk for spinal dysraphisms?
Anti seizure medications
145
Complications of myelomeningocele and myeloschisis?
Chiari II malformations Neurologic disability Cognitive issues (disruptions in white matter tracts, including agenesis of corpus collosum; ADHD) Latex allergy (random but true lol) Tethered cord Hydrocephalus CNS infections Seizures
146
Name 4 causes of VP shunt failure
Obstruction Infection Overdrainage Loculated ventricules
147
CPS approved assessment tools for DCD (3)
1. Movement Assessment Battery for Children - 2 (MABC-2) administered by an occupational or physical therapist. MABC-2 total < 16th percentile may be indicative of DCD for children > 6 years, for children 3-5 a total score < 5th percentile is required to meet Criteria A 2. DCDQ (5-15 years) or little DCDQ (3-4 years) - parent questionnaire used to determine functional impact of motor difficulties for Criteria B 3. Standardized IQ testing to rule out intellectual disability in Criteria D
148
Common co-occuring conditions associated with DCD (4)
1. ADHD 2. ASD 3. Specific Learning Disabilities 4. Language Impairment
149
Soft Signs of DCD (3)
non specific markers of performance differences that usually face by age 6, non specific to DCS 1. Overflow movements: hand posturing when walking on heels or toes 2. Mirror movements: one hand copying the other when imitating a finger pattern 3. Finger agnosia: visual monitoring to copy a finger pattern when proprioceptive feedback is insufficient
150
Abnormal Findings on DCD Neurological Examination
May struggle with coordination testing (finger to nose and rapid alternating movements)
151
Gross Motor Function Classification System (GMFCS) Classification of CP
describes function in every day life Level I—walks without limitations, have difficulties with speed, balance and coordinating more advanced motor skills Level II—walks with limitations, able to walk on flare and familiar surfaces but will require support navigating uneven surface, crowded areas and long distance Level III—walks using a hand-held mobility device (canes, crutches, walkers that do not support the trunk) Level IV—self-mobility with limitations; may use powered mobility Level V—transported in a manual wheelchair
152
Early Warning Signs for Cerebral Palsy (5)
Trigger evaluation for: 1. Hand preference before 12 months 2. stiffness or tightness in the legs before 12 months 3. inability to sit by 9 months 4. persistent fisting of hands beyond 4 months 5. delays or asymmetry in movement or posture
153
Associated concerns for children with CP (8)
1. Cognitive disability (50%) 2. Pain (75%) 3. Hip displacement (30%) 4. Seizures (25%) 5. Behavioral disorders (25%) 6. Sleep disturbances 7. Visual and hearing impairments 8. Obesity
154
7 F's when caring for a child with life altering disability
Function, family, fitness, fun, friends and future
155
Brain imaging changes seen in preterm infants associated with CP
Intracranial Hemorrhage and Periventricular Leukomalacia
156
Risk Factors of CP in term infants (3)
1. Maternal Thyroid Disease 2. Fever during labour 3. Treatment of infertility
157
Neuropathology associated with spastic diplegia
Periventricular leukomalacia
158
Neuropathology associated with spastic quadriplegia
Periventricular leukomalacia Multicysitc enceophalomalacia cortical malformations
159
Neuropathology associated with hemiplegic CP
Stroke - focal infarct or cortical/subcortical damage
160
Neuropathology associated extrapyramidal CP (athetoid, duyskinetic)
Asphyxia - symmetrical scarring in putamen and thalamus Kernicterus - scarring in globus pallidus and hippocampus Mitochondrial - scarring in globus pallidus, caudate, putamen and brainstem If there is no lesion consider a dopa responsive dystonia
161
Early physical exam findings of Spastic Diplegia CP
Commando Crawling Significantly delayed walking - feet held in equinovarus, toe walking Extensive hip abduction making it difficult to put on a diaper scissoring of lower extremities when held by the axilla Normal intellectual development
162
Early physical exam findings of Spastic Hemiplegia
Early hand preference, arm > legs delayed walking with circumductive gait and toe walking growth arrest of extemities associated with epilepsy
163
Early physical exam findings of Spastic Quadriplegia
swallowing difficulties increased tone and spasticity in all extremities flexion contractures
164
Frequency of Hip imaging in children with GMFCS Level >1 CP
AP Hip X-Ray every 6-12 months - refer to orthopedics for > 30% of the femoral head uncovered by the pelvis
165
Management options for Spasticity in CP (4)
1. Baclofen - first line - associated with sedation, hypotonia and constipation 2. Benzodiazepine - second line and adjunct - associated with sedation and memory disturbances 3. Botox Injections - associated with fever (1-3 days), transient pain, local irritation and bruising 4. Gabapentin - treats pain as a trigger of spasticity
166
Management options for Generalized Dystonia (4)
Oral or enteral Baclofen is first line Trihexyphenidyl may be used on those with isolated dystonia or co-existing sialorrhea Benzodiazepine may be used for dystonic spasms post surgery, relieving painful dystonic postures and sleep disruption Levodopa may be used as part of assessment is there is suspicion that the individual may have a dopa responsive dystonia
167
Management option for Severe Generalized Dystonia (2)
1. Clonidine (oral, enteral or transdermal) 2. Gabapentin
168
Management of Focal and Segmental Dystonia
Botulinum Toxin Type A injection
169
Management of Severe Generalized Dystonia not responsive medication (2)
1. Intrathecal Baclofen 2. Deep Brain Stimulation
170
Pathophysiology of Asymmetric Crying Facies
compression of one of the branches of the facial nerve during labour or hypoplasia or agenesis of the Depressor Angularis Oris Muscle (DAOM) (usually left sided) or the Depressor Labii Inferioris Muscle (DLIM) (usually right sided)
171
Obstetrical risk factors for fetal compression causing asymmetrical crying facies (7)
1. primiparity 2. multiple births 3. large baby 4. difficult labour and delivery 5. forceps delivery 6. uterine tumors 7. polyhydramnios
172
Asymmetric Crying Facies presentation from Nerve Compression
evidence of mandibular asymmetry and maxillary-mandibular asynclitism (look at the gums - lower gum moving downward and the upper gum remaining horizontal)
173
Asymmetric Crying Facies presentation from DAOM agenesis or hypoplasia:
- one sided downward movement of the corner of the mouth while the opposite side does not move during - Palpable thinning of the lateral portion of the lower lip on the affected side (usually present) - Normal and symmetric forehead wrinkling, closure of eyelid, nasolabial fold depth, frowning, tearing, and nostril dilatation with respiration - Normal conduction time and nerve excitability study results
174
Screening studies in Asymmetric Crying Facies
echocardiogram can be considered if malformations are present due to high prevalence of associated anomalies - FISH for 22q11 microdeletion is necessary if echocardiogram is abnormal
175
Common cardiovascular anomalies associated with Asymmetric Crying Facies (3)
1. Atrial septal defect 2. Ventricular septal defect 3. Patent ductus arteriosus
176
Management of Asymmetric Crying Facies
Search for other anomalies is not indicated - further investigations should be based on clinical findings, primarily cardiovascular and dysmorphology "wait and see" approach for 1 months to asses for spontaneous improvement
177
Diagnostic criteria for Migraine
1. > 5 attacks in the last year 2. Each lasts 2-72 hours when untreated the time a child sleeps can be considered part of headache duration 3. Headache has 2 of the following characteristics (SULTANS): - Severity: Moderate-severe pain - Unilateral/bilateral - Throbbing (or pulsating) quality - Aggravated by activity 4. Plus at least one of - Nausea/vomiting - Sensitivities - Photophobia or phonophobia 5. Not better explained by another condition
178
Abortive management options for migraine
take medication within 30 minutes, treatment within 1 hour improved pain free rates 1. Ibuprofen 10mg/kg q6h (max 600 mg), alternate or together with acetaminophen 15 mg/kg q6h, (1000 mg) OR naproxen 5 mg/kg q8-12 (max 1000 mg) 2. Triptans 3. combination triptan and OTC - more effective than monotherapy in adults
179
Contraindications to Triptans
1. history cardiovascular disease including stroke, TIA, MI,severed peripheral vascular disease, ischemic bowel disease, coronary vasospasm (Prinzmetal angina) 2. history of cardiac accessory conduction pathway disorders including WPW 3. history of hemiplegic aura or migraine with brainstem aura
180
Criteria for Migraine with Typical Aura
A. At least 2 attacks fulfilling criteria B and C B. 1 or more of the following fully reversible aura symptoms - visual - sensory - speech/language symptoms - motor - brainstem - retinal B. At least 3 of the following characteristics - at least 1 aura symptom spreads gradually over 5 or more minutes - 2 or more symptom occur in succession - each individual aura symptoms lasts 5-60 minutes - at least one aura symptoms is unilateral - at least one aura symptom is positive - the aura is accompanied, or followed within 60 minutes, by headache
181
Criteria for Migraine with Brainstem Aura
A. At least 2 attacks fulfilling criteria B A. Aura with BOTH of the following - At least two of the following brainstem symptoms: - dysarthria - vertigo - tinnitus - hyperacusis - diplopia - ataxia - decreased level of consciousness - no motor or retinal symptoms
182
Management options for severe intractable migraine
Prochlorperazine 0.15 mg/kg IV Metoclopramide 0.2 mg/kg IV Ketoralac 0.5 mg/kg IV Valproate 15 mg/kg IV Dihydroergotamine 0.5 mg/dose Q8H IV Nasal Spray
183
Preventative treatment for migraine
Lifestyle: avoid caffeine, avoid triggers, at least 1 h exercise/day, protein in AM and regular meals Pharmacological: Flunarizine, Propranolol, VPA, topiramate, amitriptyline, Onabotulinumtoxin A injection Biologics: Eptinezumab, erenumab, galcanezumab, fremanezumaub
184
Risk Factors for Idiopathic intracranial hypertension (5)
1. Female sex 2. Post-pubertal status 3. Obesity 4. PCOS 5. Medications: growth hormone tx, retinoids, and tetracycline antibiotics
185
Medications strongly linked to intracranial hypertension
minocycline, tetracycline, and doxycycline
186
Clinical Presentation of intracranial hypertension
- headache - variable in severity during the day, most often more severe in the morning and exacerbated with Valsalva, lying supine, bending over or coughing - bilateral optic disc edema - nausea and vomiting - transient visual obscurations (< 30 seconds of monocular or binocular blurring or “graying out” of vision) - enlarged blind spot on visual fields - peripheral construction, nasal field loss and inferior arcuate defects - cranial nerve VI palsy - pulsatile tinnitus
187
Management options for intracranial hypertension
1st line: Acetazolamide 20-25 mg/kg/day divided BID 2nd line: Furosemide (diuretic and need to monitor for hypokalemia) Topiramate can be considered in patients who cannot tolerate acetazolamide or furosemide Surgical intervention with optic nerve sheath fenestration (ONSF) is rarely necessary
188
Common side effects of acetazolamide
1. transient paresthesia 2. metabolic acidosis 3. slight increase in urination 4. metallic taste to food
189
Diagnostic Criteria for Intracranial Hypertension
Modified Dandy Criteria 1. Signs & symptoms of raised ICP (chronic, progressive headache, nausea, vomiting, transient visual obscurations, or papilledema) 2. Absence of localizing neurologic signs except for unilateral or bilateral 6th (abducens) nerve palsy 3. CSF opening pressure > 20 cm H2O with normal composition 4. Normal to small ventricles as demonstrated on CT or MRI
190
Most common causes of Secondary Intracranial Hypertension
1. tetracyclines 2. venous sinus thrombosis (superior sagittal and transverse sinuses) - increased risk of sigmoid or jugular thromboses in patients with otitis or mastoiditis
191
Diagnostic Criteria for Tourette Disorder
A: Multiple motor tics and one or more vocal tics have been present at some point during disorder, although not concurrently B: Wax and wane in frequency, but have persisted > 1 year since onset with no more than 3 consecutive months passing without a tic C: Disturbance causes marked distress and or significant impairment in social, occupational lor other important areas of functioning D: Onset before 18y E. Not caused by substance or another medical condition
192
Diagnostic Criteria for Transient Tic Disorder
A: single or multiple motor and/or vocal tics (ie sudden, rapid, recurrent, nonrhythmic, stereotype motor movements and vocalizations B: tics occur many times a day, nearly every day for at least 4 weeks, but for no longer than 12 consecutive months C: the disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning D: onset is before age 18 years E: disturbance is not due to the direct physiological effects of distance (eg stimulants) or general medical condition (eg Huntington disease or post viral encephalitis) F: Criteria has never been met for Tourette Disorder or chronic motor or vocal tic disorder
193
Risk Factors for Tourette Disorder (5)
1. Male gender 2. Genetic predisposition 3. Younger age 4. Environmental Influence 5. Impaired executive functioning
194
Conditions Co-Morbid with Chronic Tic Disorder (6)
1. OVD 2. ADHD 3. Anxiety 4. Mood Diroder 5. Sleep Disorder 6. Disruptive Behaviours (rage attacks)
195
headache red flags
< 6 month duration Preschool age Acute, severe onset (subarachnoid hemorrhage) Occipital location (Chiari 1 malformation) Recent head injury prior to onset Headache upon awakening recurrently Sleep-related headaches Worsens with Valsalva Lack of visual aura Pain that is difficult to describe and localize Deterioration of mental function or devt Persistent vomiting over many days Confusion, abnormal neuro exam Lack of family history of migraine Comorbid seizures
196
definite indications for neuroimaging in child with recurrent headaches
Definite: - New associated neurological findings (e.g. seizures, persistent abnormal gait) - New focal abnormalities on neurological exam - Papilledema
197
History that suggests VP shunt failure?
Headaches (morning, positional - worse when laying down) Vomiting at night (when laying down) Abdominal pain Fever Neurological changes - new weakness, sensory or cognitive changes History of previous shunt malfunctions and similar associated symptoms
198
Investigations if suspect VP shunt failure?
Shunt series (skull xray, chest and abdomen) to rule out shunt tube disconnection CT or MRI to look at ventricular size and compare with previous imaging CSF sample (Neurosurgery) through subcutaneous reservoirs if suspicion of infection
199
CSF findings in anti NDMA receptor encephalitis?
IgG antibodies against GluN1 subunit of the NMDA Can have anti-NMDA receptor antibodies in serum as well
200
treatment of anti NMDA receptor encephalitis?
IV steroids IVIG Plasmapheresis Rituximab Should investigate for any underlying neoplastic etiology (although anti NMDA receptor encephalitis can occur without underlying tumour)
201
Differences in presentation of ADEM vs anti-NMDA receptor encephalitis?
Timing: ADEM presents more acutely (hours to days) compared to anti-NMDA which is more subacute (weeks) Initial presentation: ADEM typically more similar to meningitis symptoms with fever, headache, altered mental status, seizures, whereas anti NMDA initial symptoms typically psychiatric (anxiety, psychosis, agitation)
202
Which neoplasm is anti-NMDA most commonly associated with (** IF associated with neoplasm, definitely occurs in absence of neoplasm as well)
Ovarian teratoma
203
infantile spasms presentation
- frequent clusters of symmetric flexion, extension or mixed spasms - typically cluster when waking up associated with developmental delay or regression
204
common syndromic association of infantile spasms
west syndrome - infantile spasms, hypsarrhythmia on EEG, developmental delay
205
benign myoclonus of infancy presentation (in contrast to infantile spasms)
Myoclonic jerks: sudden brief symmetrical axial flexor spasms of trunk and head lasting 1-2 seconds or “vibratory” tonic flexion of neck - May be provoked by excitement/fear; can cluster at mealtimes, often occurs during sleep. - resolves by age 5 In contrast to infantile spasms, normal physical exam, development and EEG
206
What is septic optic dysplasia commonly associated with?
In newborns -> suspect with hypoglycemia, jaundice, microphallus, midline defects, hypopituitarism, optic nerve hypolasia Associated with developmental delay, seizures, sleep disturbance, precocious puberty, obesity, anosmia, sensorineural hearing loss and cardiac anomalies.
207
classic presentation of PNES
events characterized by closed eyes and both sides of body involved - usually longer duration and fluctuating course - history of mood and dissociative disorders. Occassionally psychosis, substance use, behavioural disturbances.
208
clinical presentation of duchenne muscular dystrophy
presents at 3-4 years (NOT in infancy) with toe-walking, waddling, hyperlordosis, Gower's sign, difficulty walking up stairs, delayed early gross motor skills. Often have Gastrocnemius pseudohypertrophy
209
genetic inheritance of Duchenne Muscular dystrophy (DMD)
X-linked recessive
210
classic investigations for DMD (including genetic testing)
- dystrophin gene mutation - CK > 10,000 - biopsy shows extensive fibrosis and increased fiber size variation
211
management of DMD including monitoring
- Treat with corticosteroids or deflazacort 0.9mg/kg/day, slows pace of the disease and delays motor disability - monitor for dilated cardiomyopathy - ortho and PT support - resp - PFTs, monitor for hypoventilation
212
complications of DMD
Scoliosis Respiratory failure Osteopenia Contractures End-stage dilated cardiomyopathy arrythmias
213
prognosis of DMD
Previously, wheelchair by 10, bedridden by 15, death by 20s (usually as a result of progressive respiratory decline or cardiac dysfunction)
214
clinical features of temporal lobe epilepsy
Focal aware or impaired awareness seizures with imp that may evolve to bilateral convulsive events; auras are common and may include epigastric rising, déjà or jamais vu, olfactory or gustatory hallucinations usually manifest with a behavioral arrest and staring and last between 30 and 120 seconds. The patients are generally unaware and unresponsive during this period +/- presence of olfactory hallucinations, other seizure auras, or ictal automatisms
215
What is Myasthenia gravis?
Myasthenia gravis: chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles
216
hallmark presentation of Myasthenia gravis
fatigable weakness PTOSIS difficulty swallowing slurred speech DTRs may be diminished but RARELY absent unable to sustain upward gaze for 30-60 secs
217
presentation of infants born to mothers with myasthenia gravis
- respiratory insufficiency, inability to suck or swallow, and generalized hypotonia and weakness
218
pathophysiology of myasthenia gravis
Antibodies to the postsynaptic AChR block, alter, or destroy the receptors for acetylcholine at the neuromuscular junction, which prevents the muscle from contracting
219
Diagnosis of Myasthenia Gravis
- EMG (electromyography) is more specifically diagnostic than a muscle biopsy - Anti-AChR antibodies plasma assay (inconsistent)
220
Treatment of Myasthenia gravis
Acetylcholinesterase inhibitors (neostigmine)
221
definition of parasomnias
episodic nocturnal behaviors that often involve cognitive disorientation and autonomic and skeletal muscle disturbance. include nightmares, sleep walking (somnambulism), sleep talking, hypnogogic hallucinations, and sleep paralysis;
222
risk factors for sleepwalking
10x higher in children with family history of sleepwalking development of sleepwalking is 2x higher in children with history of sleep terrors. peak prevalence 1-5 years old
223
treatment of sleepwalking
- parental education and reassurance, healthy sleep practices, avoidance of exacerbating factors (sleep deficit and caffeine) - in sleepwalking, important to institute safety precautions (door alarms, gates, locking outside doors and windows) - scheduled awakenings is a behavioural intervention parents can use to wake their child 15 minutes BEFORE typical events occur.
224
preventative measures for general headache management
- Regular meals (protein in the morning) & sleep, avoid caffeine, avoid food triggers, exercise (20-30 mins daily), limit screen time (>3 hours - Avoid headache triggers - Address comorbid sleep problems (e.g. delayed sleep onset, frequent night waking), mood problems, and/or anxiety - Limit use of abortive therapies to < 15x/month - headache diary
225
Sandifer syndrome
- combination of GERD with spastic torticollis and dystonic body movements with or without hiatal hernia AKA abnormal movements (often axial stiffening) occurring due to GERD - can be associated with apnea, staring, and minimal jerking of the extremities - Usually occur with or after feeds in a “spitty” baby
226
risk factors for developing febrile seizure
Child has a 30% risk of developing febrile sz if has > 2: - 1st or 2nd degree relative with a history of febrile seizures (10-20% if sib, greater if parent) - Developmental delay - Attendance at day care - Hx of >28d in NICU
227
rate of recurrence of febrile seizures
Overall rate of recurrence: 30-35% - 50-75% of recurrences took place within 1 year of initial seizure, almost all occurred within 2 years
228
factors that influence recurrence risk of febrile seizures
Young age at onset (age <1 year) Complex febrile seizure Hx of febrile seizures in 1st degree relative Seizure initiated by low fever
229
simple febrile seizure diagnostic criteria
Generalized tonic clonic Lasts < 15 min (majority last 3-6 mins.) Does NOT recur within 24h No post-ictal abnormalities (i.e. no association with Todd’s paralysis
230
Complex febrile seizure diagnostic criteria
- prolonged >15 min, and/or recurs within 24h. - often focal seizure - Presence of post-ictal neurological abnormalities
231
risk factors for developing subsequent epilepsy after a febrile seizure
Simple febrile seizure 1% - (2x baseline) Recurrent febrile seizures - 4% Complex febrile Multiple in 24h = 4% (8x baseline) Prolonged (>15min) = 6% (12x baseline) Focality = 30% (60x baseline) 2 features present = 25% (50x baseline) 3 features present = 50% (100x baseline) Family history of epilepsy =18% Neurodevelopmental abnormalities 33%
232
Treatment of febrile seizure
No clear guidelines EEG NOT indicated Imaging not generally necessary Consider LP (if signs of meningitis; consider in infant 6-12 months with seizure and fever w/o Hib or S pneumo immunization), EEG, neuroimaging if: Questionable fever PRIOR to sz Focal seizure H/o dev delay Abnormal neuro exam (birth marks, micro/macro-cephaly, dysmorphic features)
233
Overview of autoimmune encephalitis disorders
disorders are associated with antibodies against neuronal cell surface proteins and synaptic receptors involved in synaptic transmission, plasticity, or neuronal excitability.
234
anti-NMDAr encephalitis mechanism
antibodies against NMDA-r - mostly idiopathic, can be triggered by prescence of a tumor (ie ovarian teratoma or paraneoplastic syndrome) common 50% history of infectious prodromal symptoms, can be associated with HSV or COVID
235
clinical presentation of anti-NMDAr encephalitis
psychiatric symptoms decreased verbal output sleep disorder seizures dysautonomia dystonia dyskensias rigidity
236
investigations of anti-NMDAr encephalitis
EEG - almost always abnormal showing epileptic activity or slowing brain MRI - nonspecific abnormal findings in 35% CSF - pleocytosis and or increased protein
237
workup of autoimmune encephalitis
serum and CSF cultures, brain imaging, EEG CSF autoimmune encephalitis panel Autoimmune evaluation (ANA, ANCA, complements, immunoglobulin levels) urine toxicology serum complete metabolic panel targeted metabolic evaluation as indicated thyroid studies
238
treatment of anti-NMDAr encephalitis
pulse methylpred 30mg/kg for 3-5 days IVIG 2g/kg with maintenance monthly +/- PLEX +/- rituximab +/- tumour removal if present 50% of patients need second line immunotherapy relapses in 15% of patients
239
What is clinical presentation of SeLECTS or self-limited epilepsy with centrotemporal spikes?
most common epilepsy syndrome nocturnal focal seizures 2-3 minutes, may awaken with inability to speak ("sleep walker") may have rhytmic facial twictching and may spread to GTC
240
age range for peak onset of Self-limited epilepsy with centrotemporal spikes
peak onset - 7 to 10 yrs old (range 1-14 years)
241
EEG findings for self-limited epilepsy with centrotemporal spikes
centrotemporal spikes = rolandic area -> corresponds to face and tongue
242
Treatment of self-limited epilepsy with centrotemporal spikes
most outgrow during puberty and do not need treatment if required: keppra or carbamazepine
243
Why can't you give phenytoin as IM injection vs fosphenytoin?
if given with dextrose, phenytoin will crystalize. Fosphenytoin is a pro drug and safe to administer IM.
244
What could an occipital location for headaches be pointing towards?
possible chiari malformation
245
What is the criteria for medication overuse headache?
* Headaches >15 days per month (often daily) * Better (or relieved) with medication * Recurs later in day * Ibuprofen or acetaminophen >15x/mos over >3 mos
246
How can you differentiate between congenital myopathy and congenital myotonic dystrophy?
Muscular dystrophies are related to gene mutation that impairs muscle fibre integrity and are prone to tearing -> HIGH CK -cognitively not normal - myotonia appears later in life Congential myopathies are related to gene mutation impairing contractile unit (actin/myosin) with NO breakdown -> normal CK - often cognitvely normal and muscle weakness is non-progressive
247
Cerebral palsy is most likely to arise following a hypotensive event at what time?
26-30 weeks GA
248
Ataxia-Telangiectasia - Inheritance? - Gene mutation?
- Inheritance: AR - Gene mutation: ATM (ATM is a phosphatidylinositol-3 kinase that phosphorylates proteins involved in DNA repair and cell-cycle control)
249
Clinical presentation of Ataxia-Telangiectasia? - Age of onset - Symptoms / Signs
AGE OF ONSE: 2 yrs SYMPTOMS: - Degenerative ataxia (loss of ambulation by adolescence) - Telangiectasia (sclerae, nose, ear, extremities) - Immunodeficiency (Low Ig; frequent sinopulm infections) - Increased cancer risk (50-100 fold increased risk of lymphoreticular tumours (lymphoma, leukemia, and Hodgkin disease) and brain tumours) - Ocular findings: Strabismus. Nystagmus. Hypometric saccade pursuit abnormalities. Oculomotor apraxia with horizontal gaze. - Endocrinopathies (GH deficiency, short stature, gonadal failure (infertility)) - Extrapyramidal features - Loss of skin elasticity - Hepatosplenomegaly
250
Diagnosis of Ataxia-Telangiectasia?
Genetic testing = gold standard for diagnosis Other supportive features: - Clinical findings (degenerative ataxia, oculomotor apraxia, telangiectasias, immunodeficiency, inc cancer risk) - Bloodwork: High AFP, Low Immunoglobulins (low IgA, low IgG), Low CD4 Tcells - Imaging: MRI brain with cerebellar atrophy of vermis
251
What is the treatment for Ataxia telangiectasia?
** Supportive cares, no cure for AT ** Neurologic symptoms: - PHYSIOTHERAPY Cancer & Radiosensitivity: - REGULAR CANCER SCREENING (breast, ovarian, leukemia). If cancer diagnosed, standard of care protocols except avoid ionizing radiation and some chemotherapies due to increased AT cell sensitivity. Immunologic symptoms: - May require PROPHYLACTIC ANTIBIOTICS (due to propensity to frequent infections) - Can have inactivated vaccines but AVOID LIVE VACCINES - +/- consider IVIg - +/- nicotinamide riboside Future treatments: Antioxidants, antisense morpholino oligonucleotides, aminoglycoside abx (that affect ATM protein function), and small molecules targeting ATM gene (to address tumorigenesis)
252
What is the most common type of craniopharyngioma in children, where does it tend to be located, does it tend to spread locally or metastasize?
Most common type of pediatric craniopharyngioma are adamantinomatous craniopharyngiomas due to CTNNB1 pathogenic variants. Papillary craniopharyngiomas are more common in adults. Craniopharyngiomas are usually large and heterogeneous (solid + cystic components) occurring within the suprasellar region. They are minimally invasive, adhere to adjacent brain parenchyma, and engulf normal brain structures.
253
How do pediatric craniopharyngiomas typically present?
- Endocrinologic abnormalities (MC = growth failure and delayed sexual maturation, panhypopituitarism) - Visual changes (decreased VA or visual field abnormalities, bitemporal hemianopia). Eventual vision loss.
254
What is the best imaging modality to diagnose craniopharyngioma and what management do they usually require?
Imaging: - MRI brain is best imaging modality for craniopharyngiomas, often described as a solid tumor mass with cystic structures containing fluid of intermediate density. - CT head not as helpful, may be better at demonstrating calcifications. Management: - Surgical excision if causing symptoms. Sometimes Radiotherapy.
255